Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography.

Molecular Therapy - Methods & Clinical Development(2020)

引用 8|浏览5
暂无评分
摘要
Lentiviral vectors (LVs) are a popular gene delivery tool in cell and gene therapy and they are a primary tool for transduction of T cells for expression of chimeric antigen receptor (CAR) in CAR-T cell therapies. Extensive process and product characterization are required in manufacturing virus-based gene vectors to better control batch-to-batch variability. However, it has been an ongoing challenge to make quantitative assessments of LV product because current analytical tools often are low throughput and lack robustness and standardization is still required. This paper presents a high-throughput and robust physico-chemical characterization method that directly assesses total LV particles. With simple sample preparation and fast elution time (6.24 min) of the LV peak in 440 mM NaCl (in 20 mM Tris-HCl [pH 7.5]), this ion exchange high-performance liquid chromatography (IEX-HPLC) method is ideal for routine in-process monitoring to facilitate the development of scalable and robust LV manufacturing processes. Furthermore, this HPLC method is suitable for the analysis of all in-process samples, from crude samples such as LV supernatants to final purified products. The linearity range of the standard curve is 3.13 × 10 to 1.0 × 10 total particles/mL, and both the intra- and inter-assay variabilities are less than 5%.
更多
查看译文
关键词
high-performance liquid chromatography,lentiviral vector,particle quantification,Process Analytical Technologies,ratio transducing units to total particles
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要